• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在印度卡纳塔克邦科拉尔区选定地区建立非机构性死亡原因医学认证系统:一项基于人群的可行性和验证研究方案

Establishing a System for Medical Certification of Cause of Death for Noninstitutional Deaths in a Selected Area of Kolar District, Karnataka, India: Protocol for a Population-Based Feasibility and Validation Study.

作者信息

Muralidhar Madhusudan, Rangamani Sukanya, Kulothungan Vaitheeswaran, Das Priyanka, Vishwakarma Monesh B, Mathur Prashant

机构信息

ICMR-National Centre for Disease Informatics and Research, Bengaluru Rural District, India.

出版信息

JMIR Res Protoc. 2025 Aug 18;14:e72330. doi: 10.2196/72330.

DOI:10.2196/72330
PMID:40522917
Abstract

BACKGROUND

Medical Certification of Cause of Death (MCCD) coverage in India is only 22.5%, largely due to a significant proportion of deaths occurring outside hospitals (noninstitutional deaths). The cause of death (CoD) in such cases is unlikely to be certified by any doctor. This study attempts to address this gap by developing an MCCD system for noninstitutional deaths in India.

OBJECTIVE

This study will assess the feasibility of a physician-derived cause of death (PhyCoD) approach for deducing CoD in noninstitutional deaths in a selected area of Kolar Taluk, Karnataka, and validate this approach.

METHODS

This population-based feasibility and validation study will be conducted in 4 selected hospitals and 2 Primary Health Centre (PHC) areas in Kolar taluk, Kolar district, Karnataka, India. We developed 4 PhyCoD questionnaires: maternal, neonatal, child, and adult. Institutional deaths that occurred over the previous 10 months in these selected hospitals with detailed case records available were selected as "gold standard" cases. Trained investigators abstracted the history from these case records into the questionnaires and deduced the CoD sequence of events. The investigators then elicited the history from the deceased's relatives using the PhyCoD questionnaire and deduced the CoD sequence of events. This will be compared with the gold standard CoD sequence of events deduced from medical records. The extent of agreement will be measured. The tool will be revised based on the pilot phase experiences. For all brought dead cases to the 4 hospitals and home deaths in the 2 PHC areas over a 3-month period, doctors in these hospitals and PHC medical officers, respectively, will elicit the history from the deceased's kin using the PhyCoD questionnaires and arrive at a CoD sequence of events. This CoD sequence of events will be validated against the gold standard autopsy whenever possible (in brought dead cases). The PhyCoD approach will also be tested for inter-rater reliability by independent investigators on a random sample of noninstitutional deaths.

RESULTS

Institutional ethics committee clearance (January 2024), recruitment and training of project staff (January 2024-January 2025), preparation of questionnaires and application (August 2024-February 2025), pilot phase data collection (48 cases; August 2024-December 2024), and training of the doctors in the participating hospitals and PHC medical officers (December 2024) are complete. A total of 48 cases (32 adult, 7 child, 3 maternal, and 6 neonatal) were included in the pilot phase. Data review and analysis of the pilot phase data are underway.

CONCLUSIONS

The study is expected to provide information about the validity and feasibility of the PhyCoD approach. Depending on the study's outcomes, the tool may be adopted by more states, leading to increased coverage of noninstitutional deaths under MCCD, improved accuracy, and reduced delay of CoD reporting for noninstitutional deaths.

INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/72330.

摘要

背景

印度的死因医学证明(MCCD)覆盖率仅为22.5%,这主要是因为很大一部分死亡发生在医院之外(非机构性死亡)。在这种情况下,死亡原因不太可能由任何医生进行证明。本研究试图通过为印度的非机构性死亡开发一个MCCD系统来解决这一差距。

目的

本研究将评估在卡纳塔克邦科拉尔县科拉尔乡选定区域,采用医生推导死因(PhyCoD)方法推断非机构性死亡死因的可行性,并验证该方法。

方法

这项基于人群的可行性和验证性研究将在印度卡纳塔克邦科拉尔县科拉尔乡选定的4家医院和2个初级卫生保健中心(PHC)地区进行。我们编制了4份PhyCoD问卷:孕产妇、新生儿、儿童和成人问卷。将这些选定医院过去10个月内发生的有详细病例记录的机构性死亡病例选为“金标准”病例。经过培训的调查人员从这些病例记录中提取病史信息填入问卷,并推导死亡事件的死因顺序。然后,调查人员使用PhyCoD问卷从死者亲属那里获取病史信息,并推导死亡事件的死因顺序。这将与从医疗记录中推导的金标准死因顺序进行比较。将测量一致性程度。将根据试点阶段的经验对工具进行修订。在3个月的时间里,对于所有送至这4家医院的死亡病例以及2个PHC地区的家中死亡病例,这些医院的医生和PHC医务人员将分别使用PhyCoD问卷从死者亲属那里获取病史信息,并得出死亡事件的死因顺序。只要有可能(在送来的死亡病例中),这个死亡事件的死因顺序将与金标准尸检结果进行验证。独立调查人员还将对非机构性死亡的随机样本进行测试,以检验PhyCoD方法的评分者间信度。

结果

机构伦理委员会批准(2024年1月)、项目工作人员的招募和培训(2024年1月至2025年1月)、问卷编制和应用(2024年8月至2025年2月)、试点阶段数据收集(48例;2024年8月至2024年12月)以及参与医院的医生和PHC医务人员培训(2024年12月)均已完成。试点阶段共纳入48例病例(32例成人、7例儿童、3例孕产妇和6例新生儿)。试点阶段数据的审查和分析正在进行中。

结论

该研究有望提供有关PhyCoD方法有效性和可行性的信息。根据研究结果,该工具可能会被更多邦采用,从而提高MCCD下非机构性死亡的覆盖率,提高准确性,并减少非机构性死亡死因报告的延迟。

国际注册报告识别号(IRRID):DERR1-10.2196/72330。

相似文献

1
Establishing a System for Medical Certification of Cause of Death for Noninstitutional Deaths in a Selected Area of Kolar District, Karnataka, India: Protocol for a Population-Based Feasibility and Validation Study.在印度卡纳塔克邦科拉尔区选定地区建立非机构性死亡原因医学认证系统:一项基于人群的可行性和验证研究方案
JMIR Res Protoc. 2025 Aug 18;14:e72330. doi: 10.2196/72330.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Sexual Harassment and Prevention Training性骚扰与预防培训
4
Surveillance for Violent Deaths - National Violent Death Reporting System, 50 States, the District of Columbia, and Puerto Rico, 2022.暴力死亡监测——2022年全国暴力死亡报告系统,50个州、哥伦比亚特区和波多黎各
MMWR Surveill Summ. 2025 Jun 12;74(5):1-42. doi: 10.15585/mmwr.ss7405a1.
5
The Perinatal Committee report: Review of the progress of obstetric healthcare in Japan.围产期委员会报告:日本产科医疗保健进展回顾
J Obstet Gynaecol Res. 2025 Jul;51(7):e16354. doi: 10.1111/jog.16354.
6
Integrated management of childhood illness (IMCI) strategy for children under five.五岁以下儿童疾病综合管理(IMCI)策略
Cochrane Database Syst Rev. 2016 Jun 22;2016(6):CD010123. doi: 10.1002/14651858.CD010123.pub2.
7
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
Suicide Risk Screening in Jails: Protocol for a Pilot Study Leveraging the Mental Health Research Network Algorithm and Health Care Data.监狱中的自杀风险筛查:利用心理健康研究网络算法和医疗保健数据的试点研究方案
JMIR Res Protoc. 2025 Jun 25;14:e68517. doi: 10.2196/68517.

本文引用的文献

1
Strengthening Cause of Death Statistics in Selected Districts of 3 States in India: Protocol for an Uncontrolled, Before-After, Mixed Method Study.加强印度3个邦部分地区的死因统计:一项非对照前后混合方法研究方案
JMIR Res Protoc. 2024 Dec 20;13:e51493. doi: 10.2196/51493.
2
Mortality in India established through verbal autopsies (MINErVA): Strengthening national mortality surveillance system in India.通过口头尸检确定印度的死亡率(MINErVA):加强印度国家死亡率监测系统。
J Glob Health. 2020 Dec;10(2):020431. doi: 10.7189/jogh.10.020431.
3
Where there is no hospital: improving the notification of community deaths.
无医院地区:改善社区死亡通报。
BMC Med. 2020 Mar 9;18(1):65. doi: 10.1186/s12916-020-01524-x.
4
Integrating community-based verbal autopsy into civil registration and vital statistics (CRVS): system-level considerations.将基于社区的口头尸检纳入民事登记和人口动态统计系统(CRVS):系统层面的考量
Glob Health Action. 2017;10(1):1272882. doi: 10.1080/16549716.2017.1272882.